PPF 2023 11.0.1

The Plasma Protein Forum (PPF) stands out as the leading conference for the plasma protein therapeutics sector in North America. This annual gathering serves as a platform for stakeholders, including industry professionals, policymakers, healthcare providers, scientists, and patients, to engage in meaningful discussions regarding significant advancements and challenges within the field. The 2023 PPF is scheduled to take place on November 14-15 in Washington, D.C.

This conference is orchestrated by the Plasma Protein Therapeutics Association (PPTA), a notable trade organization that represents a distinct segment of the biologics and biotechnology landscape. With a membership base that includes over 1,000 human plasma collection centers across North America and Europe, as well as manufacturers of critical plasma protein therapies, PPTA plays a pivotal role in the industry. Their members are responsible for approximately 80% of the plasma protein therapies available in the U.S. and 60% of those produced in Europe.

PPTA’s mission encompasses global advocacy for patient access to affordable therapies, fostering constructive interactions with regulatory agencies, and promoting collaborative efforts with patient advocacy organizations.